"Plasma" Therapy Research Begins in the United States New Coronavirus April 4 8:01
In the United States, where the infection of the new coronavirus is expanding, research has begun to collect one of the blood components, "plasma", from patients whose symptoms have recovered and administer it to severely ill patients.
Regarding the new coronavirus, no therapeutic agent has yet been confirmed to be fully effective, and vaccines are still under development.
Under these circumstances, medical institutions in New York, USA, and Houston, Texas, are jointly conducting research on treatments using "plasma," one of the components of blood.
In the research, after the infection with the new coronavirus, the `` plasma '' of a person who has been in a certain period of time after the symptoms have recovered has been collected and examined for safety and the level of antibodies contained, etc. Administer to patients.
Antibodies to the new coronavirus in "plasma" are expected to help patients recover.
Currently, patients who have recovered are providing "plasma" for this study, and will be given to patients with relatively severe symptoms such as dyspnea.
Plasma therapy has been used for more than 100 years and has been used to treat infectious diseases such as influenza and Ebola.
Experts expect it to be a temporary treatment until a new coronavirus vaccine is developed.
However, the experts working on the research say, "Surely no cure has been found, and it is still important to thoroughly wash hands and go out to prevent the spread of infection."